Odyssey Health, Inc. insider trades: Oragenics (OGEN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Odyssey Health, Inc. reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | OGEN | ↓ Sell | 7,044 | $4.32 | $30K | Direct | Jun 18, 2025 (0d) |
| Jun 16, 2025 | OGEN | ↓ Sell | 10,000 | $4.36 | $44K | Direct | Jun 16, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OGEN insiders
Open-market trades in the last 12 months
About Odyssey Health, Inc.'s insider trades
Odyssey Health, Inc. is a 10% owner of Oragenics (OGEN). Since Jun 16, 2025, it has reported no open-market purchases and 2 sales worth $74K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.